language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
MTEXMTEX

$6.24

+0.44
arrow_drop_up7.58%
Market closed·update07 Apr 2026 20:00

$6.00

-0.24
arrow_drop_down3.85%
Post-market·update07 Apr 2026 23:58
Day's Range
5.2325-6.24
52-week Range
5.2325-12.45

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date
Next Earnings TimeUnknown
Volume9.73K
Average Volume 30d12.42K

AI MTEX Summary

Powered by LiveAI
💰
25.5
Valuation (P/E Ratio)
Reasonable for growth sector
📈
0.152
EPS Growth (YoY)
Strong earnings growth
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Hold
65

Mannatech shows mixed signals. Fundamentally, it's stable but not growing aggressively, with a declining revenue trend and profitability challenges. Thematic alignment is weak. Technicals suggest a short-term bearish bias.

Weak

Thematic

40

Mannatech operates in the wellness and nutritional supplement market, which has growth potential but faces intense competition. Its current business model and product offerings do not strongly align with major secular growth themes.

Neutral

Fundamental

58

Mannatech shows a solid cash position and manageable debt, but faces headwinds with declining revenues and inconsistent profitability. Valuation metrics are mixed.

Bearish

Technical

45

The stock is trading below key moving averages and exhibits weak momentum, suggesting a bearish short-to-medium term outlook.

FactorScore
Wellness & Nutritional Supplements60
Direct Selling/Network Marketing40
E-commerce Integration50
Innovation & Product Development30
ESG Alignment30
FactorScore
Valuation70
Valuation45
Profitability65
Growth25
Balance Sheet Health60
Cash Flow70
FactorScore
Trend Analysis20
Momentum40
Volume Confirmation40
Support & Resistance50
Volatility70

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (6)

Valuation chevron_right

Attractive Valuation Metrics

The Price/Sales (PS) ratio is 0.1 for TTM and 2024, indicating the stock may be undervalued relative to its revenue generation, especially compared to prior periods (0.4 in 2021).

Growth and Profitability chevron_right

Return to Profitability

The company has shown a strong recovery in net income, turning positive with a net margin of 7.8% in Q4 2024, a significant improvement from negative margins in 2022 and 2023.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation chevron_right

Volatile P/E Ratio

The Price-to-Earnings (P/E) ratio has been highly volatile, ranging from 10.3 in 2024 to negative values in prior years, indicating potential earnings instability and making valuation comparisons challenging.

Growth Deceleration chevron_right

Revenue Decline

Revenue has declined from $159.76 million in 2021 to $117.87 million in 2024, indicating a significant contraction in the company's top line over recent years.

Show More 🔒

Calendar

June 2023

14

Ex-Dividend Date

June 2023

29

Next Dividend Date

August 2025

11

Next Earnings Date

EPS Est.
Revenue Est.

H: $

A: $

L: $

Profile

Employees (FY)189
ISINUS5637712036
FIGI-

Mannatech, Incorporated operates as a wellness solution provider. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products through network marketing distribution channels and e-commerce model. The company operates in the United States, Canada, Mexico, Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, the United Kingdom, Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, Thailand and China, as well as Belgium, France, Greece, Italy, Luxembourg, and Poland. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Seasonals

2025
2024
2023
2022
2021

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
815K (42.87%)
Closely held shares
1.09M (57.13%)
1.9M
Free Float shares
815K (42.87%)
Closely held shares
1.09M (57.13%)

Capital Structure

Market cap
15.83M
Debt
6.69M
Minority interest
0.00
Cash & equivalents
11.4M
Enterprise value
11.13M

Valuation - Summary

Market Cap
15.8M
Net income
404K(2.55%)
Revenue
87.3M(551.29%)
15.8M
Market Cap
15.8M
Net income
404K(2.55%)
Revenue
87.3M(551.29%)
Price to earning ratio (P/E)39.20x
Price to sales ratio (P/S)0.20x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
117.87M
COGS
26.41M
Gross Profit
91.46M
OpEx
90.03M
Operating Income
1.43M
Other & Taxes
-1.06M
Net Income
2.49M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒